Laboratório de Estudos Moleculares e Resistência aos Antimicrobianos, Departamento de Patologia, Análises Clínicas e Toxicológicas, Universidade Estadual de Londrina, Londrina, Brazil.
Laboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Universidade Estadual de Londrina, Londrina, Brazil.
Microb Drug Resist. 2019 Nov;25(9):1365-1373. doi: 10.1089/mdr.2019.0002. Epub 2019 Jul 30.
This study aimed to characterize the main mechanisms of acquired antimicrobial resistance of 103 multidrug-resistant isolated from bloodstream from 2006 to 2016 from a hospital in Londrina, Brazil. All 103 isolates were identified as by amplification of the and B genes. Mortality was observed in the majority (81.6%) of the patients. High non-susceptibility rates (100.0-10.7%) were obtained for the evaluated antimicrobials, including colistin, polymyxin B, and tigecycline, and most isolates were classified as extensively drug-resistant (78.6%). Carbapenemase production was observed in 92.2% of the isolates. All carbapenem-resistant isolates showed a carbapenem-hydrolyzing class D β-lactamase being either (97.9%) or (2.1%). None of the isolates had the genes , , , , , , , , , , , -1, A, B, C, S, and Vc. As a genetic context of the gene, Tn was predominated (86.0%), and Tn was less frequent (12.9%). Isolates harboring the gene showed the variant. A polyclonal profile was observed among the isolates. The presence of the international clonal complexes CC113/79, CC109/1, CC110/25, and CC103/15 was detected, with prevalence of CC113/79 (38.8%). This study provides essential information to understand the antimicrobial resistance patterns of and can be used to strengthen infection control measures in our hospital. Also, the study reinforces the urgent need to develop stewardship programs to avoid the spread and potential outbreaks by this pathogen.
本研究旨在描述巴西隆德里纳一家医院 2006 年至 2016 年间从血流感染中分离的 103 株多药耐药 株获得性抗微生物耐药的主要机制。所有 103 株分离株均通过扩增 16S rRNA 和 B 基因鉴定为 。大多数(81.6%)患者观察到死亡率。评估的抗菌药物包括多粘菌素 B、黏菌素和替加环素,其非敏感性率均较高(100.0-10.7%),大多数分离株被归类为广泛耐药(78.6%)。92.2%的分离株产碳青霉烯酶。所有耐碳青霉烯的分离株均显示出碳青霉烯水解类 Dβ-内酰胺酶,分别为 (97.9%)或 (2.1%)。没有分离株携带基因 、 、 、 、 、 、 、 、 、 -1、A、B、C、S 和 Vc。作为 基因的遗传背景,Tn 占主导地位(86.0%),而 Tn 较少见(12.9%)。携带 基因的分离株显示出 变体。在 103 株 分离株中观察到多克隆谱。检测到国际克隆复合体 CC113/79、CC109/1、CC110/25 和 CC103/15 的存在,其中 CC113/79 的流行率为 38.8%。本研究提供了了解 株抗微生物耐药模式的重要信息,可用于加强我院感染控制措施。此外,该研究还强调了迫切需要制定管理计划,以避免该病原体的传播和潜在爆发。